HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer

BACKGROUND: HER2 overexpression has been investigated as a potential biomarker and therapeutic target in biliary tract cancer (BTC), but a prognostic role of such alteration has not been demonstrated yet. MATERIALS AND METHODS: We retrospectively evaluated HER2 protein expression by immunohistochemi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Vivaldi, Caterina, Fornaro, Lorenzo, Ugolini, Clara, Niccoli, Cristina, Musettini, Gianna, Pecora, Irene, Cacciato Insilla, Andrea, Salani, Francesca, Pasquini, Giulia, Catanese, Silvia, Lencioni, Monica, Masi, Gianluca, Campani, Daniela, Fontantini, Gabriella, Falcone, Alfredo, Vasile, Enrico
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2020
Schlagworte:
Hepatobiliary
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543291/
https://ncbi.nlm.nih.gov/pubmed/32353192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0922
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge